Want to see TSE:RAMM full AI Analyst Report?
Ramm Pharma (RAMM) Income Statement
1 Followers
Ramm Pharma Income Statement
Last quarter (Q3 2026), Ramm Pharma's total revenue was C$260.01K, a decrease of 70.56% from the same quarter last year. In Q3, Ramm Pharma's net income was C$-887.32K. See Ramm Pharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jan 26 | Jan 25 | Jan 24 | Jan 23 | Jan 22 |
|---|---|---|---|---|---|
| C$ 3.36M | C$ 4.34M | C$ 5.07M | C$ 3.90M | C$ 4.12M | |
| C$ 373.93K | C$ 1.76M | C$ 381.82K | C$ 530.50K | C$ -7.64K | |
| C$ 4.89M | C$ 8.52M | C$ 7.47M | C$ 8.46M | C$ 6.63M | |
| Depreciation and Amortization | C$ 734.76K | C$ 1.21M | C$ 1.34M | C$ 1.02M | C$ 732.63K |
| C$ -3.78M | C$ -15.23M | C$ -6.30M | C$ -19.91M | C$ -6.36M | |
| C$ -4.52M | C$ -6.76M | C$ -7.09M | C$ -7.93M | C$ -7.19M | |
| C$ -4.38M | C$ -9.73M | C$ -625.08K | C$ -13.02M | C$ 92.01K | |
| C$ -8.89M | C$ -16.49M | C$ -7.71M | C$ -20.95M | C$ -7.10M | |
| C$ -8.91M | C$ -16.50M | C$ -7.72M | C$ -20.96M | C$ -7.11M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.07 | C$ -0.14 | C$ -0.06 | C$ -0.17 | C$ -0.07 |
| Diluted EPS | C$ -0.07 | C$ -0.14 | C$ -0.06 | C$ -0.17 | C$ -0.07 |
| Weighted Average Shares Outstanding | 119.39M | 119.39M | 121.04M | 122.77M | 108.46M |
| Weighted Average Shares Outstanding (Diluted) | 119.39M | 119.39M | 121.04M | 122.77M | 108.46M |
Currency in CAD
